E2F7 and hepatocellular carcinoma: E2F7 is aberrantly overexpressed in the CSCs of HCC, and promotes stem cell proliferation and tumorsphere formation not only through regulating the cell cycle but also activating the Akt/β-catenin/cyclin D1 pathway.